Well said Charles. Whilst frustrated by set-backs I can take solace from the fact we are being treated like adults and bad news not being swept under the carpet hoping we will forget
Serum meeting and Vidcare progress delayed but hopefully good news on both fronts in the not too distant future.
Once the need for Capital is resolved , ideally via accelerated R&D rebates or funding from a partner (and not from shareholders) this thing will fly.
But until this is clarified we can only sit on our hands and wait.
ADO Price at posting:
0.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)